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Bone regeneration today is one of the most important challenges for medicine and 
the need for this is particularly evident in the maxillo-facial area: our clinical trial will 
be based on a model of bone defect as in alveolar socket preservation and sinus lift 
augmentation, well described surgical techniques. The RIGENERA® system permits 
extraction of stem cells from a small sample of connective tissue obtained from the 
patient’s lingual mucosa or from a post-extraction surgical site (where an endosse-
ous implant may be inserted), dental pulp or dental follicle. Our project is to demon-
strate the efficacy in the maxillo-facial area of an innovative clinical protocol of bone 
tissue engineering based on a new medical device called Rigeneracons (CE certified 
Class I). Our clinical trial use already acquired technologies in comparation with new 
technologies (new selection methods, new Bio-compatible materials etc.) produced 
by us. Besides, we perform an in-vitro test to quantify the proliferative capacity of 
a cellular suspension obtained after disaggregation of connective tissue originating 
from the oral cavity using the RIGENERA® system, a biologic tissue disaggregator 
(Human Brain Wave–Torino, Italy) that recently came on the market. Evaluation of 
the histologic characteristics of neo-formed osseous tissue will be shown and dis-
cussed. 
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